📖

PSP/CBS Therapeutic Target Index

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-therapeutics-psp-cbs-therapeutic-ta
Related Entities
therapeutics-psp-cbs-therapeutic-target-index
Metadata
slugtherapeutics-psp-cbs-therapeutic-target-index
entity_typetherapeutic
kg_node_idNone
Linked Artifacts (114)
mentions🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis90%
related🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis90%
mentions🔬PSP and CBD both involve 4R-tau but produce distinct neuropa75%
mentions🧫s:** - Test tau spreading in AQP4 knockout vs wild-type mice70%
mentions🧫s:** - Compare tau strain spreading in EXT1/EXT2 conditional70%
mentions🧫4R-Tau Targeting Therapies for PSP and CBS70%
mentions🧫Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy70%
mentions🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri70%
mentions🧫Brainstem Circuit Modulation for PSP70%
mentions🧫CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi70%
mentions🧫CRISPR Gene Correction Approaches for CBS/PSP70%
mentions🧫Levodopa Response Determinants in PSP — Biomarker-Guided Pre70%
mentions🧫N-of-1 Clinical Trial Design for CBS/PSP70%
mentions🧫PSP and CBS Biomarker Validation Study70%
mentions🧫Tau Pathology Initiation Zone Identification70%
mentions🧫Tau PET Pattern as Therapeutic Response Predictor in 4R-Tauo70%
mentions🧫Tau Spreading Network Mapping via Spatial Transcriptomics in70%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
related🧫CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi70%
related🧫N-of-1 Clinical Trial Design for CBS/PSP70%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
related🧫4R-Tau Targeting Therapies for PSP and CBS70%
related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri70%
related🧫Brainstem Circuit Modulation for PSP70%
related🧫Levodopa Response Determinants in PSP — Biomarker-Guided Pre70%
related🧫PSP and CBS Biomarker Validation Study70%
related🧫Tau Pathology Initiation Zone Identification70%
related🧫Tau Spreading Network Mapping via Spatial Transcriptomics in70%
related🔬PSP and CBD both involve 4R-tau but produce distinct neuropa67%
mentions🧪Metabolic Reprogramming via Microglial Glycolysis Inhibition65%
mentions🧪Metabolic Switch Targeting for A1→A2 Repolarization65%
mentions🧪Mitochondrial Calcium Buffering Enhancement via MCU Modulati65%
related🧫s:** - Test tau spreading in AQP4 knockout vs wild-type mice63%
related🧫s:** - Compare tau strain spreading in EXT1/EXT2 conditional63%
related🧫4R-Tau Targeting Therapies for PSP and CBS63%
related🧫Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy63%
related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri63%
related🧫Brainstem Circuit Modulation for PSP63%
related🧫CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi63%
related🧫CRISPR Gene Correction Approaches for CBS/PSP63%
related🧫Levodopa Response Determinants in PSP — Biomarker-Guided Pre63%
related🧫N-of-1 Clinical Trial Design for CBS/PSP63%
related🧫PSP and CBS Biomarker Validation Study63%
related🧫Tau Pathology Initiation Zone Identification63%
related🧫Tau PET Pattern as Therapeutic Response Predictor in 4R-Tauo63%
related🧫Tau Spreading Network Mapping via Spatial Transcriptomics in63%
mentions🔬What are the mechanisms underlying 4r-tau strain-specific sp60%
related🧪Metabolic Reprogramming via Microglial Glycolysis Inhibition58%
related🧪Metabolic Switch Targeting for A1→A2 Repolarization58%
related🧪Mitochondrial Calcium Buffering Enhancement via MCU Modulati58%
related🔬What are the mechanisms underlying 4r-tau strain-specific sp54%
mentions🧫Microtubule domain analysis in adult axons50%
mentions🧫Tau depletion effects on neuronal development in primary cul50%
mentions🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers50%
mentions🧪TREM2 Conformational Stabilizers for Synaptic Discrimination50%
mentions🧪TREM2-mediated microglial tau clearance enhancement50%
mentions🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna50%
mentions🧪APOE-Dependent Autophagy Restoration50%
mentions🧪The Mitochondrial-Lysosomal Metabolic Coupling Dysfunction50%
mentions🧪TFEB-PGC1α Mitochondrial-Lysosomal Decoupling50%
mentions🧪APOE-TREM2 Interaction Modulation50%
mentions🧪TREM2-Mediated Selective Aggregate Clearance Pathway50%
mentions🧪TREM2-Dependent Microglial Senescence Transition50%
mentions🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia50%
mentions🧪Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
related🔬Investigate prion-like spreading of tau pathology through co50%
related🔬The disease-associated microglia (DAM) phenotype involves TR50%
related🔬What are the mechanisms underlying tdp-43 phase separation t50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying apoe4 structural biology 50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
related🔬The disease-associated microglia (DAM) phenotype involves TR50%
related🔬Is disrupted sleep a cause or consequence of neurodegenerati50%
related🔬Is disrupted sleep a cause or consequence of neurodegenerati50%
related🔬CRISPR-based therapeutic approaches for neurodegenerative di50%
related🔬What cell types are most vulnerable in Alzheimer's Dise50%
related🔬Investigate prion-like spreading of tau pathology through co50%
related🔬What are the mechanisms by which tau pathology spreads throu50%
related🔬How does metabolic reprogramming (glucose metabolism shifts,50%
related🔬What are the most promising therapeutic strategies for targe50%
related🔬TDP-43 undergoes liquid-liquid phase separation that becomes50%
related🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph50%
related🔬Multiple NDDs converge on autophagy-lysosome dysfunction. Ar50%
related🧪Microglia-Derived Extracellular Vesicle Engineering for Targ50%
mentions🧫Microglial TREM2 Agonist In Vivo Efficacy44%
mentions🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim44%
mentions🧫TREM2 Function in Alzheimer's Disease — From Risk Varia44%
mentions🔬CRISPR-based therapeutic approaches for neurodegenerative di40%
mentions🔬Investigate prion-like spreading of tau pathology through co40%
mentions🔬The disease-associated microglia (DAM) phenotype involves TR40%
mentions🔬What are the mechanisms underlying apoe4 structural biology 40%
mentions🔬Analyze circuit-level changes in neurodegeneration using All40%
mentions🔬The disease-associated microglia (DAM) phenotype involves TR40%
mentions🔬Is disrupted sleep a cause or consequence of neurodegenerati40%
mentions🔬Is disrupted sleep a cause or consequence of neurodegenerati40%
mentions🔬What cell types are most vulnerable in Alzheimer's Dise40%
mentions🔬What are the mechanisms by which tau pathology spreads throu40%
mentions🔬How does metabolic reprogramming (glucose metabolism shifts,40%
mentions🔬What are the most promising therapeutic strategies for targe40%
mentions🔬TDP-43 undergoes liquid-liquid phase separation that becomes40%
mentions🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph40%
mentions🔬Multiple NDDs converge on autophagy-lysosome dysfunction. Ar40%
mentions🔬What are the mechanisms underlying tdp-43 phase separation t40%
mentions🔬What are the mechanisms underlying blood-brain barrier trans40%
related🧪TREM2 Conformational Stabilizers for Synaptic Discrimination40%
related🧪Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m40%
related🧪TREM2-mediated microglial tau clearance enhancement40%
related🧪Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m35%